Suzhou Yihe Pharmaceutical

Developer of dry powder inhalers

placeNingbo, Zhejiang, China calendar_todayFounded 2020 language inhalpharma.com

Innovation

52 patent families (11 granted) — focus: Human necessities, Operations & transport, Physics & computing, Mechanical engineering; filing pace steady. Cited 200 times.

YearFilings
202214
202313
202411
202512
20262

Investor mix

1 investor on record; lead investors include Saiying Capital.

Investor typeCountShare
Private equity1100%
Coming soon